Endocrine / Hormonal
Atosiban
Atosiban is a synthetic peptide antagonist that functions as a competitive inhibitor of the oxytocin receptor.
Evidence: 0 articles
Goals: 0
Mechanism of Action
Atosiban acts as a competitive antagonist at the oxytocin receptor. By binding to these receptors in the myometrium, it inhibits the binding of endogenous oxytocin, thereby reducing the frequency and strength of uterine contractions and interfering with the signaling pathways that typically promote labor.
Evidence Level
Clinical Trial - Human
0 studies published
Pharmacology
Molecular Weight
994.2 Da